Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Development of an opsonophagocytic killing assay for group a streptococcus.

Jones S, Moreland NJ, Zancolli M, Raynes J, Loh JMS, Smeesters PR, Sriskandan S, Carapetis JR, Fraser JD, Goldblatt D.

Vaccine. 2018 Jun 18;36(26):3756-3763. doi: 10.1016/j.vaccine.2018.05.056.

PMID:
29776751
2.

Natural IgM antibodies in the immune defence against neoehrlichiosis.

Wennerås C, Goldblatt D, Zancolli M, Mattsson M, Wass L, Hörkkö S, Rosén A.

Infect Dis (Lond). 2017 Nov - Dec;49(11-12):809-816. doi: 10.1080/23744235.2017.1347815. Epub 2017 Jul 6.

PMID:
28682152
3.

Correction for van Tonder et al., Genomics Reveals the Worldwide Distribution of Multidrug-Resistant Serotype 6E Pneumococci.

van Tonder AJ, Bray JE, Roalfe L, White R, Zancolli M, Quirk SJ, Haraldsson G, Jolley KA, Maiden MCJ, Bentley SD, Haraldsson Á, Erlendsdóttir H, Kristinsson KG, Goldblatt D, Brueggemann AB.

J Clin Microbiol. 2016 Jun;54(6):1670. doi: 10.1128/JCM.00619-16. No abstract available.

4.

Correction: Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants.

Wijmenga-Monsuur AJ, van Westen E, Knol MJ, Jongerius RM, Zancolli M, Goldblatt D, van Gageldonk PG, Tcherniaeva I, Berbers GA, Rots NY.

PLoS One. 2016 May 11;11(5):e0155088. doi: 10.1371/journal.pone.0155088. eCollection 2016.

5.

Poor Correlation between Pneumococcal IgG and IgM Titers and Opsonophagocytic Activity in Vaccinated Patients with Multiple Myeloma and Waldenstrom's Macroglobulinemia.

Karlsson J, Roalfe L, Hogevik H, Zancolli M, Andréasson B, Goldblatt D, Wennerås C.

Clin Vaccine Immunol. 2016 Apr 4;23(4):379-85. doi: 10.1128/CVI.00654-15. Print 2016 Apr.

6.

Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants.

Wijmenga-Monsuur AJ, van Westen E, Knol MJ, Jongerius RM, Zancolli M, Goldblatt D, van Gageldonk PG, Tcherniaeva I, Berbers GA, Rots NY.

PLoS One. 2015 Dec 10;10(12):e0144739. doi: 10.1371/journal.pone.0144739. eCollection 2015. Erratum in: PLoS One. 2016;11(5):e0155088.

7.

Functional anti-polysaccharide IgG titres induced by unadjuvanted pneumococcal-conjugate vaccine when delivered by microprojection-based skin patch.

Pearson FE, Muller DA, Roalfe L, Zancolli M, Goldblatt D, Kendall MA.

Vaccine. 2015 Nov 27;33(48):6675-83. doi: 10.1016/j.vaccine.2015.10.081. Epub 2015 Oct 28.

PMID:
26518398
8.

Genomics Reveals the Worldwide Distribution of Multidrug-Resistant Serotype 6E Pneumococci.

van Tonder AJ, Bray JE, Roalfe L, White R, Zancolli M, Quirk SJ, Haraldsson G, Jolley KA, Maiden MC, Bentley SD, Haraldsson Á, Erlendsdóttir H, Kristinsson KG, Goldblatt D, Brueggemann AB.

J Clin Microbiol. 2015 Jul;53(7):2271-85. doi: 10.1128/JCM.00744-15. Epub 2015 May 13. Erratum in: J Clin Microbiol. 2016 Jun;54(6):1670.

9.

Streptococcus pneumoniae serotype 1 burden in the African meningitis belt: exploration of functionality in specific antibodies.

Blumental S, Moïsi JC, Roalfe L, Zancolli M, Johnson M, Burbidge P, Borrow R, Yaro S, Mueller JE, Gessner BD, Goldblatt D.

Clin Vaccine Immunol. 2015 Apr;22(4):404-12. doi: 10.1128/CVI.00758-14. Epub 2015 Feb 4.

10.

Serological response to 13-valent pneumococcal conjugate vaccine in children and adolescents with perinatally acquired HIV infection.

Bamford A, Kelleher P, Lyall H, Haston M, Zancolli M, Goldblatt D, Kampmann B.

AIDS. 2014 Sep 10;28(14):2033-43. doi: 10.1097/QAD.0000000000000385.

11.

Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study.

Andrews NJ, Waight PA, Burbidge P, Pearce E, Roalfe L, Zancolli M, Slack M, Ladhani SN, Miller E, Goldblatt D.

Lancet Infect Dis. 2014 Sep;14(9):839-46. doi: 10.1016/S1473-3099(14)70822-9. Epub 2014 Jul 17.

PMID:
25042756
12.

Comparative immunogenicity of 7 and 13-valent pneumococcal conjugate vaccines and the development of functional antibodies to cross-reactive serotypes.

Grant LR, O'Brien SE, Burbidge P, Haston M, Zancolli M, Cowell L, Johnson M, Weatherholtz RC, Reid R, Santosham M, O'Brien KL, Goldblatt D.

PLoS One. 2013 Sep 23;8(9):e74906. doi: 10.1371/journal.pone.0074906. eCollection 2013.

13.

Carriage of Streptoccoccus pneumoniae 7 years after implementation of vaccination program in a population with very high and long-lasting coverage, Italy.

Ansaldi F, de Florentiis D, Canepa P, Zancolli M, Martini M, Orsi A, Durando P, Icardi G.

Vaccine. 2012 Mar 16;30(13):2288-94. doi: 10.1016/j.vaccine.2012.01.067. Epub 2012 Feb 3.

PMID:
22306795
14.

Impact of influenza during the post-pandemic season: epidemiological picture from syndromic and virological surveillance.

De Florentiis D, Parodi V, Orsi A, Rossi A, Altomonte F, Canepa P, Ceravolo A, Valle L, Zancolli M, Piccotti E, Renna S, Macrina G, Martini M, Durando P, Padrone D, Moscatelli P, Orengo G, Icardi G, Ansaldi F.

J Prev Med Hyg. 2011 Sep;52(3):134-6.

PMID:
22010543
15.

Determinants of invasiveness and ability to cause invasive pneumococcal disease, pneumonia and acute otitis media of different serotypes of Streptococcus pneumoniae.

Zancolli M, Canepa P, Ceravolo A, Parodi V, Ansaldi F.

J Prev Med Hyg. 2011 Jun;52(2):47-54. Review. No abstract available.

PMID:
21842705
16.

Sequential outbreaks of multidrug-resistant Acinetobacter baumannii in intensive care units of a tertiary referral hospital in Italy: combined molecular approach for epidemiological investigation.

Ansaldi F, Canepa P, Bassetti M, Zancolli M, Molinari MP, Talamini A, Ginocchio F, Durando P, Mussap M, Orengo G, Viscoli C, Icardi G.

J Hosp Infect. 2011 Oct;79(2):134-40. doi: 10.1016/j.jhin.2011.05.027. Epub 2011 Aug 5.

PMID:
21820758
17.

Differential survival of γδT cells, αβT cells and NK cells upon engagement of NKG2D by NKG2DL-expressing leukemic cells.

Poggi A, Zancolli M, Boero S, Catellani S, Musso A, Zocchi MR.

Int J Cancer. 2011 Jul 15;129(2):387-96. doi: 10.1002/ijc.25682. Epub 2010 Nov 3.

18.

Role of congenital rubella reference laboratory: 21-months-surveillance in Liguria, Italy.

Canepa P, Valle L, Cristina E, De Florentiis D, Parodi V, Banfi F, Zancolli M, Durando P, Icardi G, Ansaldi F.

J Prev Med Hyg. 2009 Dec;50(4):221-6.

PMID:
20812517
19.

Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates.

Ansaldi F, Zancolli M, Durando P, Montomoli E, Sticchi L, Del Giudice G, Icardi G.

Vaccine. 2010 Jun 7;28(25):4123-9. doi: 10.1016/j.vaccine.2010.04.030. Epub 2010 Apr 28.

PMID:
20433807
20.

Migratory pathways of gammadelta T cells and response to CXCR3 and CXCR4 ligands: adhesion molecules involved and implications for multiple sclerosis pathogenesis.

Poggi A, Zancolli M, Catellani S, Borsellino G, Battistini L, Zocchi MR.

Ann N Y Acad Sci. 2007 Jun;1107:68-78.

PMID:
17804534
21.

NKG2D and natural cytotoxicity receptors are involved in natural killer cell interaction with self-antigen presenting cells and stromal cells.

Poggi A, Prevosto C, Zancolli M, Canevali P, Musso A, Zocchi MR.

Ann N Y Acad Sci. 2007 Aug;1109:47-57.

PMID:
17785290
22.

Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction.

Prevosto C, Zancolli M, Canevali P, Zocchi MR, Poggi A.

Haematologica. 2007 Jul;92(7):881-8.

23.

Neuroblastoma targeting by c-myb-selective antisense oligonucleotides entrapped in anti-GD2 immunoliposome: immune cell-mediated anti-tumor activities.

Brignole C, Marimpietri D, Pagnan G, Di Paolo D, Zancolli M, Pistoia V, Ponzoni M, Pastorino F.

Cancer Lett. 2005 Oct 18;228(1-2):181-6. Review.

PMID:
15936140
24.

Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.

Pastorino F, Brignole C, Marimpietri D, Di Paolo D, Zancolli M, Pagnan G, Ponzoni M.

Ann N Y Acad Sci. 2004 Dec;1028:90-103.

PMID:
15650235

Supplemental Content

Loading ...
Support Center